Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Pharma found its way into sports
If you've spent any Sunday this fall watching an NFL broadcast, you may have noticed a shift in the advertising landscape. Alongside the team logos between third-down stops and touchdown drives were cancer screening messages from Novartis…
Kringle Pharma FY Parent Loss Y813.00M Vs Loss Y916.00M
Kringle Pharma Inc. (4884.TO) Japan Year Ended September 30 PARENT 2026 2025 Revenue Y442.00 mln Y72.00 mln Operating Profit (Y813.00 mln) (Y909.00 mln) Pretax Profit (Y810.00 mln) (Y914.00 mln) Net Profit (Y813.00 mln) (Y916.00 mln) Per share…
Nikkei Flat, Supported by Bank, Pharma Stocks
0023 GMT — Japan 's Nikkei Stock Average is flat at 60451.02 as gains in bank and pharmaceutical shares offset losses in technology and machinery stocks. Mitsubishi UFJ Financial Group rises 1.9% and Takeda Pharmaceutical is 2.0% higher…
Mums v Big Pharma: the sodium valproate scandal
A new BBC documentary has reignited the outcry over the sodium valproate scandal – a catalogue of pregnancy harms that England's Patient Safety Commissioner has called “bigger than thalidomide”. The drug at the centre of the…
Calley Means: Big Food, Big Pharma Blocked MAHA Reforms
Former White House adviser Calley Means told Joe Rogan that many Make America Healthy Again (MAHA) initiatives stalled because of the lobbying machine's bipartisan efforts to control Washington. Means, who helped unite Trump and HHS Secretary…
NewAmsterdam Pharma (NASDAQ:NAMS) Price Target Raised to $61.00
NewAmsterdam Pharma (NASDAQ:NAMS - Get Free Report) had its target price raised by investment analysts at Cantor Fitzgerald from $52.00 to $61.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm presently has an…
Royalty Pharma (NASDAQ:RPRX) Hits New 52-Week High - What's Next?
Shares of Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) reached a new 52-week high on Wednesday. The stock traded as high as $69.83 and last traded at $69.07, with a volume of 452,424 shares trading hands. The stock had previously closed at…
Nifty Prediction Today - November 11, 2026: Nifty futures: Intraday outlook is positive
Among the sectors, the few indices related to pharma and healthcare are in the red. Nifty Pharma has lost the most by declining 0.5 per cent. While most of the sectoral indices have advanced over 1 per cent, showing a strong broad-based buying…
China AI App Boom Tapped by Drugmakers to Reach Doctors on Marketing Crackdown
The interface of Zhiyi, an AI-powered platform from JD Health, is displayed next to the app's logo in this illustration picture taken October 21, 2026. REUTERS/Florence Lo/Illustration Drugmakers in China are seizing on a boom in digital assistants…
Cinclus outlines HEEALING1 top line results expected this quarter after 523 patients randomized
Earnings Call Insights: Cinclus Pharma Holding AB (publ) (CPHHF) Q3 2026 CEO & President Christer Ahlberg said Cinclus' lead asset “linaprazan glurate” targets “severe erosive GERD,” describing a “large and…
Analysis-Drugmakers tap China AI app boom to reach doctors as crackdown upends marketing
SHANGHAI, Nov 11 (Reuters) – Drugmakers in China are seizing on a boom in digital assistants that has opened up a new — and potentially more efficient — way to connect with doctors after a sweeping graft crackdown disrupted…
Proximal Ventures raises debut fund to back startups bringing AI to drug development
While established venture firms continue to attract capital, first-time fund managers are facing one of the toughest fundraising environments in years. But that didn't stop Sahir Raoof, a former SignalFire investor and executive at two healthcare…
WSJ: EU Learns Hard Old Lesson on Price Controls
What happens when governments employ price controls as part of a 'central planning' economy pushed by socialists? In every place it has been tried, the results are consistent. Little gets produced except shortages and excuses. For decades, the…
Capricor Therapeutics shares rise as FDA decision nears (CAPR:NASDAQ)
Capricor Therapeutics (CAPR) shares rose 4.4% in extended trading Tuesday after the biotechnology company reported a wider third-quarter loss and missed Wall Street estimates for revenue and earnings. The San Diego-based company reported no revenue…
Sabra Health Care REIT Is A Buy After Q3 Shows More Portfolio Expansion (NASDAQ:SBRA)
Albert Anthony is the pen name of a business author on Amazon and a contributing analyst to investing platforms like Seeking Alpha since 2023, where he has over + 2,000 followers and has covered hundreds of stocks in multiple sectors including…
Receive a Daily briefing on Pharma Industry News
Get Started